Effects of Neoadjuvant Intraperitoneal/Systemic Chemotherapy (Bidirectional Chemotherapy) for the Treatment of Patients with Peritoneal Metastasis from Gastric Cancer

Table 7

Prognostic parameters (results of Cox proportional hazard model and logrank test).

	Cox hazard model		Logrank test
X ^2	𝑃	Realtive sisk	95% CI	X ^2	𝑃
Sex (male versus female)	2.158	0.141	0.652	0.3697–1.1531	4.298	0.038
Age (≤65 versus >65)	0.603	0.437	1.399	0.5991–3.2692	0.289	0.59
Histologic type (diff. versus poorly)	0.024	0.876	1.171	0.1584–8.6651	0.631	0.427
CC (CC-0 versus CC-1)	4.197	0.04	2.005	1.0306–3.9041	8.537	0.003
PCI (≥6 versus ≤7)	1.592	0.206	1.528	0.7908–2.9536	5.737	0.017
Pathologic response on PC (Ef-1, -2 versus Ef-2, -3)	4.269	0.038	0.429	0.1927–0.9575	10.303	0.001
LN status (pN0 versus pN1, 2, and 3)	2.478	0.115	2.121	0.8317–5.4108	3.739	0.053
Cytology after NIPS (class I versus class V)	0.047	0.828	1.079	0.5415–2.1513	0.365	0.546